Outcome Measures for Clinical Trials in Interstitial Lung Diseases

By  

Current Respiratory Medicine Reviews, Vol. 11, Iss. 2, 2015-01 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design

By  

Current Rheumatology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 138-144

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Clinical Trial Assessments for the Study of Interstitial Lung Disease in Patients who have Connective Tissue Diseases-Methodological Considerations

By  

Current Rheumatology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 145-150

Bentham Science Publishers

Access to resources Recommend Favorite

Patient-reported Outcome (PRO) Measures for Clinical Trials of COPD: The EXACT and E-RS

By Leidy Nancy K.   Murray Lindsey T.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 3, 2013-06 ,pp. : 393-398

Informa Healthcare

Access to resources Recommend Favorite

Morphological and Biochemical Properties of Alveolar Fibroblasts in Interstitial Lung Diseases

By Fireman E.   Shahar I.   Shoval S.   Messer G.   Dvash S.   Grief J.  

Lung, Vol. 179, Iss. 2, 2001-03 ,pp. : 105-117

Springer Publishing Company

Access to resources Recommend Favorite